“Consumers have grown accustomed to being told by insurers — and middlemen known as pharmacy benefit managers — that they must give up their brand-name drugs in favor of cheaper generics. But some are finding the opposite is true, as pharmaceutical companies squeeze the last profits from products that are facing cheaper generic competition.” (I’m starting to wonder if big pharma always has our best interests in mind…) From ProPublica: Take the Generic Drug, Patients Are Told — Unless Insurers Say No.